SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma
Marcel Trautmann(University Hospital Münster), Wolfgang Hartmann(University Hospital Münster), Marcus Renner(Heidelberg University), Stefan Aretz(University of Bonn), Roland Penzel(Heidelberg University), A Koch(Charité - Universitätsmedizin Berlin), Gunhild Mechtersheimer(Heidelberg University), Akira Kawai(NTT (Japan)), Sebastian Michels(University Hospital Cologne), Elisabeth Sievers(Karolinska University Hospital), Eva Wardelmann(University Hospital Münster), Shinya Tanaka(Hokkaido University), Nicolaus Friedrichs(University Hospital Cologne), Olle Larsson(Karolinska University Hospital), Sebastian Huss(University Hospital Münster), Peter Schirmacher(Heidelberg University), Susanne Steiner(University Hospital Bonn), H Sonobe(National Hospital Organization), J Kirfel(University Hospital Bonn), Dagmar Kindler(University Hospital Cologne), Andreas Waha(University Hospital Bonn), Reinhard Büttner(University Hospital Cologne)
Cited by 95
Related Papers
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k